Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Chuanlai, Yang"'
Autor:
Yanzhen Lin, Nanyi Liu, Chuanlai Yang, Haoyin Tan, Changjian Fang, Kang Yu, Huan Zhao, Ningshao Xia, Wei Wang, Xiumin Huang, Tong Cheng
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-14 (2024)
Abstract Background Cervical squamous cell carcinoma (CSCC) is a prevalent gynecological malignancy worldwide. Current treatments for CSCC can impact fertility and cause long-term complications, underscoring the need for new therapeutic strategies. O
Externí odkaz:
https://doaj.org/article/0c3ac982680041239220d21055987a07
Autor:
Tingting Li, Wenhui Xue, Qingbing Zheng, Shuo Song, Chuanlai Yang, Hualong Xiong, Sibo Zhang, Minqing Hong, Yali Zhang, Hai Yu, Yuyun Zhang, Hui Sun, Yang Huang, Tingting Deng, Xin Chi, Jinjin Li, Shaojuan Wang, Lizhi Zhou, Tingting Chen, Yingbin Wang, Tong Cheng, Tianying Zhang, Quan Yuan, Qinjian Zhao, Jun Zhang, Jason S. McLellan, Z. Hong Zhou, Zheng Zhang, Shaowei Li, Ying Gu, Ningshao Xia
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Antibodies (Abs) targeting highly conserved epitopes are important tools against emerging virus variants. Here, the authors characterize Abs that recognize a cryptic epitope in the receptor-binding domain of SARS-CoV-2 spike that is well conserved an
Externí odkaz:
https://doaj.org/article/86208d0971bf4ed2a80bc56f650c0589
Autor:
Shanhai Ou, Zehong Huang, Miaoling Lan, Jianghui Ye, Jijin Chen, Huilin Guo, Jin Xiao, Shucheng Zhuang, Jiahuang Wu, Chuanlai Yang, Mujin Fang, Yingying Su, Ting Wu, Shengxiang Ge, Tong Cheng, Yongchang Zhang, Yongcai Lin, Yali Zhang, Guowei Chen, Quan Yuan
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectivesWe aimed to evaluate the duration and breadth of antibodies elicited by inactivated COVID-19 vaccinations in healthy blood donors.MethodsWe performed serological tests on 1,417 samples from 658 blood donors who received two (n=357), or thre
Externí odkaz:
https://doaj.org/article/656dd6400ad546f1a1379e7ae5dbefc9
Autor:
Yali Zhang, Min Wei, Yangtao Wu, Juan Wang, Yuting Hong, Yang Huang, Lunzhi Yuan, Jian Ma, Kai Wang, Shaojuan Wang, Yang Shi, Zikang Wang, Huilin Guo, Jin Xiao, Chuanlai Yang, Jianghui Ye, Jijing Chen, Yuxi Liu, Baorong Fu, Miaolin Lan, Peixuan Gong, Zehong Huang, Yingying Su, Yixin Chen, Tianying Zhang, Jun Zhang, Huachen Zhu, Hai Yu, Quan Yuan, Tong Cheng, Yi Guan, Ningshao Xia
Publikováno v:
Cell Reports, Vol 38, Iss 12, Pp 110558- (2022)
Summary: Mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike receptor-binding domain (RBD) may alter viral host tropism and affect the activities of neutralizing antibodies. Here, we investigated 153 RBD mutants and 11
Externí odkaz:
https://doaj.org/article/e14a0f7a6d9e484ba5254157cfb7430c
Autor:
Shuang Yue, Xiaotong Wang, Wei Ge, Jiajia Li, Chuanlai Yang, Zeyang Zhou, Peng Zhang, Xiaodong Yang, Wenjin Xiao, Shuang Yang
Publikováno v:
ACS Omega.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bb52dd355513767a37fde20e890684a
https://doi.org/10.1021/acsomega.3c01653
https://doi.org/10.1021/acsomega.3c01653
Autor:
Quan Yuan, Yali Zhang, Shaojuan Wang, Lizhi Zhou, Xin Chi, Qingbing Zheng, Jason S. McLellan, Ying Gu, Tong Cheng, Sibo Zhang, Shaowei Li, Chuanlai Yang, Tianying Zhang, Yingbin Wang, Jinjin Li, Yuyun Zhang, Hui Sun, Qinjian Zhao, Zheng Zhang, Z. Hong Zhou, Jun Zhang, Minqing Hong, Tingting Deng, Wenhui Xue, Hualong Xiong, Shuo Song, Hai Yu, Tingting Li, Ningshao Xia, Yang Huang, Tingting Chen
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Nature communications, vol 12, iss 1
Nature Communications
Nature communications, vol 12, iss 1
Nature Communications
The emergence of numerous variants of SARS-CoV-2, the causative agent of COVID-19, has presented new challenges to the global efforts to control the COVID-19 pandemic. Here, we obtain two cross-neutralizing antibodies (7D6 and 6D6) that target Sarbec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c08303f7b22cedde91b4b7bcd05eec3
https://doaj.org/article/86208d0971bf4ed2a80bc56f650c0589
https://doaj.org/article/86208d0971bf4ed2a80bc56f650c0589
Autor:
Chuanlai, Yang, Han, Xiang, Kai, Fu, Lu, Jin, Feng, Yuan, Boxin, Xue, Zhiwei, Wang, Lixia, Wang
Publikováno v:
Am J Cancer Res
Recent studies have shown that lycorine, a natural alkaloid compound, plays its anti-cancer role in several human malignancies including bladder cancer. However, the molecular mechanism of lycorine-induced antitumor activity has not been sufficiently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b105f67e6a479e8e77a37d996e97c486
https://pubmed.ncbi.nlm.nih.gov/36381314
https://pubmed.ncbi.nlm.nih.gov/36381314
Autor:
Tingting Li, Wenhui Xue, Qingbing Zheng, Shuo Song, Chuanlai Yang, Hua-Long Xiong, Sibo Zhang, Minqing Hong, Ya-Li Zhang, Hai Yu, Yuyun Zhang, Hui Sun, Yang Huang, Tingting Deng, Xin Chi, Jinjin Li, Shaojuan Wang, Lizhi Zhou, Tingting Chen, Yingbin Wang, Tong Cheng, Tian-Ying Zhang, Quan Yuan, Qinjian Zhao, Jun Zhang, Jason McLellan, Z. Hong Zhou, Zheng Zhang, Ying Gu, Shaowei Li, Ningshao Xia
The emergence of numerous variants of SARS-CoV-2, the causative agent of COVID-19, has presented new challenges to the global efforts to control the still ravaging COVID-19 pandemic. Here, we obtain two cross-neutralizing antibodies (7D6 and 6D6) tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58b9f0f9b1f4a5518a1da147d97d2cd5
https://doi.org/10.21203/rs.3.rs-582977/v1
https://doi.org/10.21203/rs.3.rs-582977/v1
Autor:
Ningshao Xia, Jiali Cao, Chang-Rong Chen, Yali Zhang, Ying Gao, Hualong Xiong, Yingbin Wang, Chuanlai Yang, Shan-Hai Ou, Jing-Hua Zhao, Tianying Zhang, Quan Yuan, Tong Cheng
Publikováno v:
Emerging Microbes & Infections. 8:724-733
Anti-HBs is a well-known marker of protective capability against HBV. However, little is known about the association between the qAnti-HBs determined by immunoassays and the neutralization activity...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b9440836601f51449917ce039a9e295
https://doi.org/10.1080/22221751.2019.1619485
https://doi.org/10.1080/22221751.2019.1619485
Autor:
Yali Zhang, Min Wei, Quan Yuan, Kai Wang, Zikang Wang, Yi Guan, Yuxi Liu, Juan Wang, Jun Zhang, Lunzhi Yuan, Yang Shi, Jijing Chen, Chuanlai Yang, Jian Ma, Jin Xiao, Tong Cheng, Hongbo Zhu, Yuting Hong, Zehong Huang, Ningshao Xia, Shaojuan Wang, Miaolin Lan, Jianghui Ye, Yixin Chen, Yangtao Wu, Tianying Zhang, Hai Yu, Yang Huang, Peixuan Gong, Yingying Su, Baorong Fu, Huilin Guo
Publikováno v:
SSRN Electronic Journal.
Mutations in the SARS-CoV-2 spike receptor-binding domain (RBD) may alter the viral host tropism and affect the activities of neutralizing antibodies (nAbs). Here, we investigated 153 RBD mutants and 10 globally circulating VOC/VOI variants for their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2a7c8d2afedc2249717880da83903a4
https://doi.org/10.2139/ssrn.3917167
https://doi.org/10.2139/ssrn.3917167